CrushSCI.com
75.5Average days
68.5Median days
20Fastest days
166Longest days
322025 publications

Paper Review Records

All Paper Review Records

6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

20 days

Frailty and Rheumatoid Arthritis: Key Insights and the Road Ahead

Authors
Alexandra C. Legge; Grace Burns; Courtney N. Loecker; Devyani Misra; Katherine D. WyshamShow moreShow less
Affiliations
1. Dalhousie University; 2. Queen Elizabeth II Health Sciences Centre; 3. University of Nebraska Medical Center; 4. Beth Israel Deaconess Medical Center; 5. Harvard University; 6. University of Washington; 7. VA Puget Sound Health Care SystemShow moreShow less
Source PDF DOI Publisher page
43 days

Juvenile-onset Systemic Lupus Erythematosus: Recent Advances in Pathogenesis and Treatment

Authors
Valentina Natoli; Amandine Charras; Eve MD Smith; Christian M. HedrichShow moreShow less
Affiliations
1. Department of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK; 2. Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili, Università degli Studi di Genova, Genoa, Italy; 3. Rheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; 4. School of Infection & Immunity, University of Glasgow, Glasgow, UK; 5. Department of Paediatric Rheumatology, Alder Hey Children’s NHS Foundation Trust Hospital, Liverpool, UKShow moreShow less
Source PDF DOI Publisher page
166 days

Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory Domains

Authors
Medha Barbhaiya; Stephane Zuily; Mary-Carmen Amigo; Tadej Avcin; Maria Laura Bertolaccini; D. Ware Branch; Guilherme Ramires de Jesus; Katrien M. J. Devreese; Camille Frances; David Garcia; Francis Guillemin; Steven R. Levine; Roger A. Levy; Michael D. Lockshin; Thomas L. Ortel; Surya V. Seshan; Maria G. Tektonidou; Denis Wahl; Rohan Willis; Allison Hendry; Ray Naden; Karen H. Costenbader; Doruk ErkanShow moreShow less
Affiliations
1. Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery; Weill Cornell Medicine, New York, USA; 2. Vascular Medicine Department and Reference Center for Rare Systemic Autoimmune and Autoinflammatory Diseases, CHRU-Nancy, Nancy University Hospital; INSERM UMR-S 1116, University of Lorraine, Nancy, France; 3. Service of Rheumatology, ABC Medical Center, Mexico, Mexico; 4. Department of Allergology, Rheumatology, and Clinical Immunology, Children’s Hospital, University Medical Center, University of Ljubljana, Ljubljana, Slovenia; 5. Academic Department of Vascular Surgery, Heart Foundation Centre of Excellence, School of Cardiovascular Medicine & Sciences, King’s College London British, London, UK; 6. Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, USA; 7. Department of Obstetrics, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; 8. Coagulation Laboratory, Department of Laboratory Medicine, Department of Diagnostic Sciences, Ghent University Hospital, Ghent University, Ghent, Belgium; 9. Department of Dermatology-Allergology, Tenon Hospital, Paris, France; 10. Department of Hematology, University of Washington, Seattle, USA; 11. CIC Clinical Epidemiology, CHRU, Inserm, Université de Lorraine, and INSPIIRE, Université de Lorraine, Inserm, Nancy, France; 12. Downstate Stroke Center and Department of Neurology, State University of New York Downstate Health Sciences University; Kings County Hospital Center, and Maimonides Medical Center/Jaffe Stroke Center, Brooklyn, USA; 13. Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil; 14. Glaxo Smith Kline, Upper Providence, USA; 15. Department of Hematology, Duke University Medical Center, Durham, USA; 16. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA; 17. First Department of Propaedeutic Internal Medicine, National and Kapodistrian, University of Athens, Athens, Greece; 18. Antiphospholipid Standardization Laboratory, University of Texas Medical Branch, Galveston, USA; 19. Department of Medicine and Rheumatology, Middlemore Hospital, Auckland, New Zealand; 20. Department of Obstetric Medicine, Auckland City Hospital, Auckland, New Zealand; 21. Department of Rheumatology, Brigham and Women’s Hospital, Boston, USAShow moreShow less
Source PDF DOI Publisher page
87 days

The Role of FDG-PET in the Diagnosis and Monitoring of Large-Vessel Vasculitis

Authors
Alessandro Tomelleri; Corrado Campochiaro; Peter C. Grayson; Kaitlin A. QuinnShow moreShow less
Affiliations
1. Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; 2. National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, USAShow moreShow less
Source PDF DOI Publisher page
70 days

Advancing Juvenile Spondyloarthritis: Closing Knowledge Gaps with New Axial JSpA Classification Criteria

Authors
Brittney N. Newby; Pamela F. WeissShow moreShow less
Affiliations
1. Division of Pediatric Rheumatology, Children’s Hospital of Philadelphia, Philadelphia, USA; 2. Department of Pediatrics, Division of Rheumatology and Clinical Futures, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, USA; 3. Roberts Center for Pediatric Research, CHOP, Philadelphia, USAShow moreShow less
Source PDF DOI Publisher page
67 days

Updates on the Role of DXA in the Evaluation and Monitoring of Osteoporosis

Authors
Shahane Anupama; Sian Yik Lim; Marcy B. BolsterShow moreShow less
Affiliations
1. Division of Rheumatology, University of Pennsylvania, Philadelphia, USA; 2. Hawaii Pacific Health Medical Group, Honolulu, USA; 3. John E Burns School of Medicine University of Hawaii, Honolulu, US; 4. Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital , Boston, US; 5. Harvard Medical School, Boston, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Current Rheumatology Reports take to review a manuscript?

As of 2026-11-19, CrushSCI has 6 complete review records for Current Rheumatology Reports. The fastest paper went from submission to acceptance in 20 days (Frailty and Rheumatoid Arthritis: Key Insights and the Road Ahead, received 2026-09-15, accepted 2026-10-05); the slowest took 166 days. The average is 75.5 days and the median is 68.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.